California Teachers Study (CTS): Whole Genome Sequences From Under-Represented Populations
Anthropometry (2)
- bmi_baseline - Self-reported body mass index (kg/m2) at baseline (administered 1995) (phv00537373.v1.p1)
- bmi_q5 - Self-reported body mass index (kg/m2) at Q5 (administered 2012) (phv00537374.v1.p1)
Demographics (3)
- age_baseline - Age at the time of the baseline questionnaire (administered 1995) (phv00537363.v1.p1)
- sex - Sex (phv00537360.v1.p1)
- SEX - Biological sex (phv00537356.v1.p1)
Disease Events (22)
- age_cancer - Age at first incident cancer diagnosis between baseline and 12/31/2020. (phv00537381.v1.p1)
- asthma - Participant self-reported asthma on questionnaire 3, 4, 5, or the blood draw questionnaire (phv00537399.v1.p1)
- cancer_type - Cancer type for first incident cancer diagnosis between baseline and 12/31/2020. Other cancers with n <5 are grouped. Other cancer types diagnosed within this population include: Anus, Anal Canal and Anorectum; Gallbladder; Kidney and Renal Pelvis; Other Biliary; Other Endocrine including Thymus; Other Female Genital Organs; Other Non-Epithelial Skin; Ovary; Rectosigmoid Junction; Rectum; Small Intestine; Tonsil; Urinary Bladder; Uterus, NOS; Vulva (phv00537380.v1.p1)
- deceased - Vital status as of end of follow-up (12/31/2020), based on annual linkages with California Vital Statistics (phv00537375.v1.p1)
- diab - Participant self-reported diabetes on questionnaire 1, 4, 5, 6, or the blood draw questionnaire (phv00537401.v1.p1)
- dvt - Participant self-reported deep vein thrombosis on questionnaire 5 or 6 (phv00537402.v1.p1)
- ever_anycancer - Participant has any record of cancer as of 12/31/2020. This includes self-reported cancer on the first CTS questionnaire. (phv00537376.v1.p1)
- ever_breastcancer - Participant has any record of breast cancer as of 12/31/2020. This includes self-reported breast cancer on the first CTS questionnaire. (phv00537377.v1.p1)
- htak - Participant self-reported heart attack on questionnaire 1, 5, or the blood draw questionnaire (phv00537403.v1.p1)
- hypertension - Participant self-reported hypertension on questionnaire 1, 5, 6, or the blood draw questionnaire (phv00537404.v1.p1)
- incident_anycancer - Participant has an incident cancer diagnosis of any cancer between baseline and 12/31/2020. (phv00537378.v1.p1)
- incident_breastcancer - Participant has an incident breast cancer diagnosis between baseline and 12/31/2020. (phv00537379.v1.p1)
- inflammatorybowel_crohns - Participant self-reported inflammatory bowel/crohns syndrome on questionnaire 5, 6, or the blood draw questionnaire (phv00537405.v1.p1)
- kidneydisease - Participant self-reported kidney disease on questionnaire 5 or 6 (phv00537406.v1.p1)
- kidneystones - Participant self-reported kidney stones on questionnaire 5 or 6 (phv00537407.v1.p1)
- lupus - Participant self-reported lupus on questionnaire 5 or the blood draw questionnaire (phv00537408.v1.p1)
- migraines - Participant self-reported migraines on questionnaire 5 or 6 (phv00537409.v1.p1)
- multiple_cancers - Indicator of if a participant had multiple incident cancers between baseline and 12/31/2020. (phv00537382.v1.p1)
- parkinsons - Participant self-reported Parkinson's on questionnaire 5 or 6 (phv00537412.v1.p1)
- psoriasis - Participant self-reported psoriasis on questionnaire 5, 6, or the blood draw questionnaire (phv00537413.v1.p1)
- shingles - Participant self-reported shingles on questionnaire 5 or 6 (phv00537415.v1.p1)
- stroke - Participant self-reported stroke on questionnaire 1 or 5 (phv00537416.v1.p1)
Exercise (2)
- phys_act_baseline - Strenuous/moderate hours exercise past 3 years at baseline (administered 1995) (phv00537395.v1.p1)
- phys_act_q5 - Strenuous/moderate hours exercise past 3 years at Q5 (administered 2012) (phv00537396.v1.p1)
General Health (3)
- osteoarthritis - Participant self-reported osteoarthritis on questionnaire 5, 6, or the blood draw questionnaire (phv00537410.v1.p1)
- osteoporosis - Participant self-reported osteoporosis on questionnaire 5 or 6 (phv00537411.v1.p1)
- rheuma - Participant self-reported rheumatoid arthritis on questionnaire 5, 6, or the blood draw questionnaire (phv00537414.v1.p1)
Medications (2)
- nsaid_q5 - Current use of NSAID at Q5 (administered 2012) (phv00537397.v1.p1)
- statin_q5 - Current use of statin medication at Q5 (administered 2012) (phv00537398.v1.p1)
Mental Health (1)
- depression - Participant self-reported depression on questionnaire 5 or 6 (phv00537400.v1.p1)
Race and Ethnicity (3)
- dad_race - Participant dad's race. Participants were included in this project if at least one parent was nonwhite (phv00537372.v1.p1)
- mom_race - Participant mom's race. Participants were included in this project if at least one parent was nonwhite (phv00537371.v1.p1)
- race_category - Participant self-reported race combined with parents' race (phv00537370.v1.p1)
Reproductive Health (10)
- age_menarche - Age at menarche (phv00537383.v1.p1)
- ht - Ever used hormone therapy - incorporates participant responses from baseline through Q5 (phv00537394.v1.p1)
- menostat_baseline - Menopausal status at baseline (administered 1995) (phv00537392.v1.p1)
- menostat_q5 - Menopausal status at Q5 (administered 2012) (phv00537393.v1.p1)
- oc_ever_baseline - Ever used oral contraceptives at baseline (administered 1995) (phv00537384.v1.p1)
- oc_years_baseline - Total years used oral contraceptives at baseline (administered 1995) (phv00537385.v1.p1)
- parity_baseline - Total number of pregnancies at baseline (administered 1995) (phv00537388.v1.p1)
- parity_q2 - Total number of pregnancies at Q2 (administered 1997) (phv00537389.v1.p1)
- preg_ever_baseline - Ever pregnant at baseline (administered 1995) (phv00537386.v1.p1)
- preg_ever_thru_q4 - Participant reported ever being pregnant on questionnaire 1, 2 or 4 (phv00537387.v1.p1)
Substance Use (2)
- alcohol_grams_baseline - Category of alcohol grams/day in the past year at baseline (administered 1995) (phv00537390.v1.p1)
- smoke_stat_baseline - Smoking status (smoked at least 100 cigarettes in entire lifetime) at baseline (administered 1995) (phv00537391.v1.p1)
Other (17)
- ANALYTE_TYPE - Analyte Type (phv00537419.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00537418.v1.p1)
- CONSENT - Consent group as determined by IRB (phv00537355.v1.p1)
- IS_TUMOR - Tumor status (phv00537420.v1.p1)
- response_q2 - Participant responded to the second questionnaire, Q2 (administered 1997) (phv00537364.v1.p1)
- response_q3 - Participant responded to the third questionnaire, Q3 (administered 2000) (phv00537365.v1.p1)
- response_q4 - Participant responded to the fourth questionnaire, Q4 (administered 2005) (phv00537366.v1.p1)
- response_q5 - Participant responded to the fifth questionnaire, Q5 (administered 2012) (phv00537367.v1.p1)
- response_q6 - Participant responded to the sixth questionnaire, Q6 (administered 2017) (phv00537368.v1.p1)
- SAMPLE_ID - Sample ID (phv00537417.v1.p1)
- SAMPLE_ID - Sample ID (phv00537358.v1.p1)
- ses - SES population-based quartiles created by incorporating occupation, education and income 1990 census block group variables (phv00537369.v1.p1)
- SUBJECT_ID - Unique participant identifier (phv00537359.v1.p1)
- SUBJECT_ID - Subject ID (phv00537354.v1.p1)
- SUBJECT_ID - Subject ID (phv00537357.v1.p1)
- year_baseline - Year participant completed the baseline questionnaire (administered 1995) (phv00537362.v1.p1)
- year_blood_draw - Year of blood draw (sample collection from 2013-2016) (phv00537361.v1.p1)